Page 2 - Astrazeneca Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Astrazeneca daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Astrazeneca Daily Today - Breaking & Trending Today

AstraZeneca (NASDAQ:AZN) Reaches New 12-Month High at $79.47

AstraZeneca PLC (NASDAQ:AZN – Get Free Report) shares reached a new 52-week high during trading on Monday . The company traded as high as $79.47 and last traded at $79.26, with a volume of 2884431 shares traded. The stock had previously closed at $78.02. Analyst Ratings Changes A number of equities analysts recently issued reports […] ....

United States , Dekabank Deutsche Girozentrale , Pathway Financial Advisers , Astrazeneca Company Profile , Deutsche Bank Aktiengesellschaft , Goldman Sachs Group , Get Free Report , Bank Aktiengesellschaft , Bank Deutsche Girozentrale , Investment Counsel , Financial Advisers , Teachers Retirement System , Retirement System , Astrazeneca Daily ,

AstraZeneca PLC (NASDAQ:AZN) Stock Holdings Raised by Nicholas Company Inc.

Nicholas Company Inc. lifted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 587.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 827,625 shares of the company’s stock after buying an additional 707,215 shares during the period. Nicholas […] ....

Goldman Sachs Group , Jones Financial Companies Lllp , Gm Advisory Group , Deutsche Bank Aktiengesellschaft , Cloverfields Capital Group , Asset Management Inc , Securities Exchange Commission , Rafferty Asset Management , Nicholas Company Inc , Nicholas Company , Free Report , Asset Management , Management Inc , Financial Companies Lllp , Capital Group , Get Free Report , Visit Holdingschannel , Astrazeneca Daily ,

Short Interest in AstraZeneca PLC (NASDAQ:AZN) Drops By 10.1%

AstraZeneca PLC (NASDAQ:AZN – Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 7,670,000 shares, a decrease of 10.1% from the April 30th total of 8,530,000 shares. Based on an average daily trading volume, of 5,310,000 shares, the short-interest ratio […] ....

United States , Deutsche Bank Aktiengesellschaft , Pathway Financial Advisers , Cetera Advisors , Goldman Sachs Group , Astrazeneca Company Profile , Get Free Report , Financial Advisers , Retirement System , Cetera Investment Advisers , Investment Advisers , Astrazeneca Daily ,

Cloverfields Capital Group LP Acquires 11,877 Shares of AstraZeneca PLC (NASDAQ:AZN)

Cloverfields Capital Group LP grew its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 46.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,268 shares of the company’s stock after buying an additional 11,877 shares during the quarter. Cloverfields […] ....

New Zealand General , New Zealand , Wellington Management Group , Goldman Sachs Group , Cloverfields Capital Group , Sanders Capital , Deutsche Bank Aktiengesellschaft , Fisher Asset Management , Ameriprise Financial Inc , Dimensional Fund Advisors , Exchange Commission , Free Report , Capital Group , Management Group , Asset Management , Fund Advisors , Get Free Report , Astrazeneca Daily ,

AstraZeneca PLC (LON:AZN) Receives £118 Average PT from Analysts

Shares of AstraZeneca PLC (LON:AZN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the nine brokerages that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. […] ....

Deutsche Bank Aktiengesellschaft , Jefferies Financial Group , Astrazeneca Company Profile , Get Free Report , Marketbeat Ratings , Bank Aktiengesellschaft , Get Free , Astrazeneca Daily ,